Reference
Medicines and Healthcare products Regulatory Agency (UK). Medicines taken during pregnancy: please report suspected adverse drug reactions, including in the baby or child, on a Yellow Card. Drug Safety Update 11: 8-10, No. 12, Jul 2018. Available from: URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/726260/DSU-July-PDF.pdf
Rights and permissions
About this article
Cite this article
MHRA encourages suspected ADR reporting during pregnancy. Reactions Weekly 1712, 3 (2018). https://doi.org/10.1007/s40278-018-49292-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-49292-2